Let's Talk
Visit Telugu Website

Menu

UPSC Mains Previous Year Questions –Biotechnology

Q.1) Discuss several ways in which microorganisms can help in meeting the current fuel shortage.  

Introduction

The world is facing an unprecedented energy crisis driven by the twin pressures of rising energy demands and the rapid depletion of fossil fuels. Added to this is the environmental degradation caused by carbon emissions, compelling the search for cleaner and renewable energy alternatives. Microorganisms—tiny life forms like bacteria, fungi, and algae—offer a promising avenue for sustainable fuel production. Through metabolic processes, they can convert organic matter into biofuels such as ethanol, biodiesel, biogas, and even hydrogen, thus playing a significant role in addressing current and future energy shortages.

Body

1. Microorganisms in Bioethanol Production

  • Process: Bioethanol is produced through the fermentation of sugars by microbes such as Saccharomyces cerevisiae (baker’s yeast) and Zymomonas mobilis.
  • Feedstock: Can be derived from sugarcane, corn, and increasingly from lignocellulosic biomass (agricultural waste, wood chips), reducing competition with food crops.
  • Advantages: Blending ethanol with petrol (e.g., E10, E20) reduces dependence on crude oil and lowers carbon emissions.
  • Example: India’s Ethanol Blending Programme (EBP) targets 20% ethanol in petrol by 2025, with microbial fermentation playing a central role.

2. Microalgae in Biodiesel Production

  • Mechanism: Certain microalgae species (e.g., Chlorella, Nannochloropsis) are capable of photosynthesis and can accumulate high levels of lipids.
  • Conversion: Lipids are extracted and converted into fatty acid methyl esters (FAMEs) through transesterification to produce biodiesel.
  • Benefits:
    • Requires less land and water than conventional crops.
    • Can grow in saline or wastewater, avoiding freshwater use.
    • Higher yield per hectare than traditional oilseed crops.
  • Challenges: High production cost and scalability issues are current barriers.

3. Anaerobic Digestion and Biogas Production

  • Microorganisms Involved: Anaerobic bacteria like Methanogens (e.g., Methanobacterium) digest organic matter in the absence of oxygen.
  • Substrate: Cow dung, food waste, sewage, and agricultural residues.
  • Output: Biogas (methane + CO₂), which can be used for cooking, lighting, and electricity generation.
  • Rural Utility: Biogas plants have been widely promoted in rural India under schemes like National Biogas and Organic Manure Programme (NBOMP).

4. Biohydrogen Production

  • Mechanisms:
    • Biophotolysis by cyanobacteria and green algae (e.g., Chlamydomonas) uses sunlight to split water molecules into hydrogen and oxygen.
    • Dark fermentation by bacteria like Clostridium spp. releases hydrogen gas from carbohydrate breakdown.
  • Advantages: Hydrogen is a clean fuel with water as its by-product—ideal for fuel cells and long-term energy transition.
  • Limitations: Low yield, high costs, and storage issues are ongoing challenges.

5. Microbial Fuel Cells (MFCs)

  • Working Principle: Microorganisms like Geobacter and Shewanella oxidize organic matter and release electrons, which flow through an external circuit to generate electricity.
  • Application: Can treat wastewater while producing energy.
  • Potential: Though still in research stages, MFCs could revolutionize waste-to-energy systems in the future.

6. Waste to Fuel via Microbial Decomposition

  • Municipal and Industrial Waste: Microbes can break down organic waste into fuel components like methane or ethanol.
  • Circular Economy: Helps in waste management while contributing to decentralized energy solutions.
  • Example: Urban waste-to-biogas plants in cities like Pune and Indore are being piloted using microbial digesters.

7. Genetic Engineering to Improve Microbial Fuel Production

  • Modern biotechnology tools like CRISPR and metabolic engineering allow scientists to:
    • Enhance fermentation efficiency.
    • Modify metabolic pathways to increase yield of desired fuels.
    • Develop genetically modified algae/bacteria for higher lipid or ethanol output.
  • Example: Genetically engineered E. coli strains have been developed to convert lignocellulosic biomass to ethanol efficiently.

Conclusion

Microorganisms, through various biochemical and metabolic processes, offer sustainable, eco-friendly, and versatile solutions to meet growing fuel needs. From producing bioethanol and biodiesel to generating hydrogen and biogas, they serve as natural biorefineries. However, challenges related to scalability, efficiency, and cost-effectiveness remain. A multidisciplinary approach involving biotechnology, energy policy, and infrastructure investment is essential to fully leverage microbial fuel technologies. With proper research support and regulatory encouragement, microorganisms can significantly contribute to a clean energy future and reduce our dependence on fossil fuels.

Q.2) What is the basic principle behind vaccine development? How do vaccines work? What approaches were adopted by the Indian vaccine manufacturers to produce COVID-19 vaccines? (UPSC CSE Mains 2022)

Introduction

Vaccines are biological preparations designed to provide acquired immunity against specific infectious diseases. The basic principle of vaccine development is to stimulate the body’s immune system to recognize and fight pathogens without causing the disease itself.

Body

Basic Principle of Vaccine Development

  • Mimic Natural Infection: Vaccines introduce a harmless component of a pathogen (like a protein or a weakened virus) into the body.
  • Immunological Memory: This trains the immune system to recognize and destroy the real pathogen if it is encountered in the future.
  • Safety and Efficacy: A successful vaccine must strike a balance between stimulating strong immunity and ensuring minimal side effects.

How Vaccines Work

  1. Antigen Introduction: The vaccine contains antigens resembling the disease-causing microorganism.
  2. Immune Response Activation: The immune system detects the antigen as foreign and produces antibodies.
  3. Memory Cell Formation: Specialized memory B-cells and T-cells are formed to provide long-term protection.
  4. Rapid Future Response: On later exposure to the actual pathogen, the immune system responds swiftly and robustly, preventing illness.

Approaches Adopted by Indian Manufacturers for COVID-19 Vaccines

Indian vaccine developers used a mix of traditional and modern platforms:

Vaccine

Developer

Platform Used

Covaxin

Bharat Biotech + ICMR

Inactivated whole virus

Covishield

Serum Institute of India

Viral vector-based (adenovirus platform)

ZyCoV-D

Zydus Cadila

DNA plasmid-based vaccine (first of its kind)

Corbevax

Biological E

Protein subunit vaccine

Gennova mRNA

Gennova Biopharma (under trial)

mRNA-based platform

  • Innovation and Collaboration: Indian firms collaborated with global institutions and used indigenous R&D.
  • Emergency Use Authorization (EUA): Enabled faster rollout while maintaining safety standards.
  • Public–Private Partnerships: The government’s initiatives like Mission COVID Suraksha accelerated vaccine development and production.

Conclusion

India’s response to the COVID-19 crisis through diversified vaccine development showcased its scientific capability and pharmaceutical strength. The adoption of multiple platforms not only ensured timely protection for its population but also contributed significantly to global vaccination efforts under Vaccine Maitri.

Q.3) What are the research and developmental achievements in applied biotechnology? How will these achievements help to uplift the poorer sections of society? (UPSC CSE Mains 2021)

Introduction

Applied biotechnology involves the practical use of biological systems and organisms to develop products and technologies for agriculture, health, industry, and the environment. India has made notable strides in recent years, particularly in health care, agriculture, and bio-manufacturing.

Body

Research and Developmental Achievements in Applied Biotechnology

1. Agriculture and Food Security

  • Genetically Modified (GM) Crops: Development of Bt cotton, virus-resistant papaya, and drought-tolerant rice.
  • RNA interference (RNAi): Used to develop pest-resistant tobacco and brinjal.
  • Biofortification: Introduction of iron-rich and zinc-rich varieties like iron-fortified rice.
  • Tissue Culture and Micropropagation: Large-scale production of disease-free, high-yielding planting material.

2. Healthcare and Medicine

  • Recombinant Vaccines: Indigenous development of Hepatitis B, COVID-19 (Covaxin), and DNA vaccines (ZyCoV-D).
  • Gene Therapy and CRISPR-Cas9: Research in curing genetic diseases like β-thalassemia and Duchenne Muscular Dystrophy.
  • Rapid Diagnostic Kits: Lateral flow immunoassays for TB, dengue, and mastitis in dairy animals.

3. Environment and Industry

  • Bioremediation: Use of microbes for cleaning oil spills and heavy metal detoxification.
  • Biofuels and Bioplastics: Production of eco-friendly fuels and packaging materials.
  • Fermentation Technology: Enhancing shelf-life and nutritional value of food.

4. Recent Initiatives

  • Genome India Project: Mapping the Indian genome for disease prediction and precision medicine.
  • National Biopharma Mission: Boosting vaccine and biologics development.
  • DBT’s Biotech-KISAN Program: Connecting science labs with farmers for applied agri-biotech solutions.

How These Achievements Help Uplift the Poorer Sections

Area

Impact on Poorer Sections

Agriculture

Increased crop yield, reduced input costs, resilience to climate change → better income for small farmers

Health

Affordable vaccines and diagnostics → improved rural healthcare and reduced disease burden

Nutrition

Biofortified crops → better health for malnourished populations

Employment

Expansion of biotech-based MSMEs → job creation in rural and semi-urban areas

Women Empowerment

Tissue culture and agri-biotech adoption by self-help groups

Conclusion

Applied biotechnology holds transformative potential for inclusive growth. By bridging the gap between scientific innovation and societal application, it empowers vulnerable sections—especially farmers, women, and the rural poor—through better health, livelihood, and food security.

Q.4) How is science interwoven deeply with our lives? What are the striking changes in agriculture triggered off by the science-based technologies?

Introduction

Science is a systematic enterprise that builds and organizes knowledge through testable explanations and predictions. In today’s world, it is impossible to separate human life from science, as it touches every aspect of our daily existence—be it health, communication, agriculture, energy, or transportation. Nowhere is the impact of science more pronounced and transformative than in the field of agriculture, which has witnessed revolutionary changes driven by scientific advancements.

Body

How Science is Interwoven Deeply with Our Lives

  1. Health and Medicine
    • Development of life-saving vaccines (e.g., polio, COVID-19), antibiotics, and advanced diagnostic tools (MRI, CT scans).
    • Organ transplantation, gene therapy, and prosthetics have greatly enhanced quality and longevity of life.
    • Use of AI in medical diagnostics and robotic surgeries is reshaping healthcare delivery.
  2. Communication and Information Technology
    • The internet, smartphones, satellites, and 5G networks have revolutionized the way we communicate.
    • Remote education, telemedicine, and e-governance are possible due to digital and information sciences.
  3. Transportation and Mobility
    • High-speed trains, electric vehicles, hybrid engines, and drone deliveries are applications of mechanical and material sciences.
    • Navigation through GPS, automated traffic signals, and traffic flow modeling improve mobility and safety.
  4. Energy and Environment
    • Solar panels, wind turbines, bioenergy, and nuclear reactors offer alternatives to fossil fuels.
    • Science-based innovations in carbon capture, biodegradable plastics, and green hydrogen help mitigate environmental damage.
  5. Homes and Daily Living
    • Refrigerators, microwaves, smart lighting, and home assistants (AI-based) are examples of science in domestic life.
    • Safe drinking water through RO, UV purification, and sensors in air-quality monitors improve life quality.
  6. Finance and Security
    • Cryptography and blockchain secure digital transactions.
    • Biometric identification (Aadhaar) enables efficient service delivery and reduces fraud.

Striking Changes in Agriculture Triggered Off by Science-Based Technologies

  1. Green Revolution (1960s onwards)
    • Introduction of high-yielding varieties (HYVs) of wheat and rice.
    • Use of chemical fertilizers, pesticides, and improved irrigation infrastructure.
    • Resulted in food self-sufficiency but also led to concerns like soil degradation and monoculture.
  2. Biotechnology in Agriculture
    • Genetically Modified Crops (GMOs): Bt cotton introduced pest resistance, reducing pesticide use.
    • Biofortified crops: e.g., Golden rice enriched with Vitamin A.
    • Marker-Assisted Selection: Speeds up development of disease-resistant and climate-resilient crops.
  3. Precision Agriculture
    • Use of drones, satellite imagery, and GPS for real-time crop monitoring and soil mapping.
    • Helps in efficient use of water, fertilizers, and pesticides, reducing input costs and environmental harm.
  4. Soil and Water Management
    • Soil Health Cards provide nutrient profiles for customized fertilizer usage.
    • Micro-irrigation techniques like drip and sprinkler systems enhance water-use efficiency.
  5. Climate-Resilient Farming
    • Development of drought-tolerant, flood-resistant, and saline-tolerant varieties (e.g., Swarna Sub1 rice).
    • Use of weather forecasting and early warning systems via mobile applications.
  6. Mechanization and Smart Tools
    • Mechanized tools like seed drillers, harvesters, and planters improve farm productivity and reduce human labor.
    • Sensors and mobile apps guide farmers on sowing time, pest attacks, and market prices.
  7. Post-Harvest Technologies and Food Processing
    • Scientific storage techniques (cold chains, irradiation) reduce post-harvest losses.
    • Processing technologies extend shelf-life, increase value, and open up new income sources.
  8. Organic and Sustainable Farming
    • Vermicomposting, bio-fertilizers, and integrated pest management (IPM) promoted by agronomy and microbiology research.
    • Soil conservation and crop rotation based on agro-scientific research.

Conclusion

Science has become deeply embedded in every aspect of modern life, acting as an invisible force driving progress and problem-solving. In agriculture, science has helped shift the sector from subsistence to sustainability and from dependency to resilience. These developments have not only enhanced productivity but also enabled environmental stewardship, income generation, and food security. Continued investment in agricultural research, extension, and scientific education is critical to sustaining these gains and ensuring inclusive growth.

Q.5) COVID-19 pandemic has caused unprecedented devastation worldwide. However, technological advancements are being availed readily to win over the crisis. Give an account of how technology was sought to aid management of the pandemic. (2020)

Introduction

The COVID-19 pandemic disrupted global health systems, economies, and daily life on an unprecedented scale. In response, science and technology emerged as the most powerful tools in combating the virus—from surveillance and diagnostics to vaccine development and public communication. The pandemic accelerated innovation and digital transformation across sectors, showcasing how technology can save lives and sustain societies under crisis.

Body

Technological Interventions in Pandemic Management

1. Surveillance and Contact Tracing

  • Aarogya Setu App: India’s Bluetooth and GPS-based mobile app helped identify and alert users who were in close proximity to infected persons.
  • Geospatial Tools: GIS-based dashboards monitored real-time infection spread, aiding micro-containment strategies.

2. Testing and Diagnostics

  • RT-PCR and Rapid Antigen Testing: Widely deployed for accurate and quick detection.
  • CRISPR-based Diagnostics: India developed ‘FELUDA’ test for affordable and precise genome-based detection.
  • AI and Machine Learning: Used to analyze chest X-rays and CT scans to identify COVID-19 lung infections.

3. Vaccine Development and Delivery

  • mRNA Technology: Used in vaccines like Pfizer-BioNTech and Moderna for quick production and adaptability.
  • Covaxin and Covishield: India’s indigenous and collaborative efforts using inactivated virus and adenovirus vectors.
  • CoWIN Platform: India’s digital platform managed vaccine registration, scheduling, and certification at scale.

4. Telemedicine and Digital Health

  • eSanjeevani Portal: Enabled free online consultations, especially for rural and underserved areas.
  • AI Chatbots and Helplines: Provided information, screening support, and reduced pressure on healthcare systems.

5. Public Awareness and Education

  • Social Media and Mobile Alerts: Used to disseminate verified information about hygiene, lockdowns, and vaccines.
  • Digital Media Campaigns: Promoted behavior changes like mask-wearing and social distancing.

6. Robotics and Automation

  • Service Robots: Deployed in hospitals for sanitization, medicine delivery, and temperature checks.
  • Drones: Used for disinfectant spraying, medicine delivery, and crowd monitoring.

7. Remote Work and Education

  • Video Conferencing Platforms (Zoom, Microsoft Teams): Enabled continuity of work and education during lockdowns.
  • Digital Learning Portals: DIKSHA, SWAYAM, and PM eVIDYA supported online education.

8. Data Analytics and Modeling

  • Epidemiological models forecasted infection peaks and resource requirements.
  • Big Data helped optimize allocation of hospital beds, oxygen supply, and ventilators.

Conclusion

The pandemic was a global tragedy, but it also became a catalyst for rapid technological innovation and digital adoption. The integration of AI, biotechnology, IoT, and digital platforms transformed how societies responded to a health emergency. Going forward, these innovations must be institutionalized for better preparedness and resilience against future pandemics.

Q.6) Why is there so much activity in the field of biotechnology in our country? How has this activity benefitted the field of biopharma? (2018)

Introduction

India has emerged as a significant player in biotechnology owing to its rich biological diversity, strong pool of scientific manpower, and proactive government support. Biotechnology plays a crucial role in healthcare, agriculture, environment, and industrial sectors, with biopharmaceuticals being one of its most impactful applications.

Body

Reasons for Increased Biotechnology Activity in India

1. Government Policy and Institutional Support

  • Establishment of Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC).
  • Policies like the National Biotechnology Development Strategy and Make in India initiatives encourage innovation and entrepreneurship.

2. Expanding R&D Infrastructure

  • Emergence of biotech parks and incubators in cities like Bengaluru, Hyderabad, Pune.
  • Collaboration between public institutions (e.g., CSIR labs, IITs) and private firms has accelerated research.

3. Skilled Human Resource

  • A large number of graduates and researchers in life sciences, bioengineering, and pharmacy have boosted innovation and production capacity.

4. Growing Healthcare Demand

  • Rising prevalence of chronic diseases and the need for affordable healthcare have driven investment in biologics, biosimilars, and vaccines.

5. Start-up Ecosystem and Funding

  • Emergence of biotech start-ups with support from BIRAC Seed Fund, Biotech Ignition Grant (BIG), and venture capital investment.

Benefits to the Biopharma Sector

1. Vaccine Development

  • India is among the largest vaccine producers globally. Companies like Bharat Biotech and Serum Institute of India are key players.
  • India’s biotech sector played a major role during the COVID-19 pandemic, producing vaccines like Covaxin and Covishield.

2. Biosimilars and Biologics

  • India is a global hub for biosimilar development, offering low-cost alternatives to expensive biologics.
  • Firms like Biocon and Dr. Reddy’s Laboratories have developed biosimilars for insulin, cancer drugs, etc.

3. Export and Global Recognition

  • India’s biopharma exports have grown steadily, with strong presence in African, Latin American, and South-East Asian markets.

4. Employment and Economic Contribution

  • The biopharma industry has created thousands of skilled jobs and contributes significantly to the Indian bioeconomy, projected to reach USD 150 billion by 2025.

Conclusion

The rapid activity in India’s biotechnology sector, driven by policy, talent, and infrastructure, has significantly strengthened the biopharma industry. It has positioned India not only as a manufacturing hub but also as a global leader in affordable and accessible healthcare solutions.

Q.7) Stem cell therapy is gaining popularity in India to treat a wide variety of medical conditions including Leukaemia, Thalassemia, damaged cornea and several burns. Describe briefly what stem cell therapy is and what advantages it has over other treatments.

Introduction

Stem cell therapy is a rapidly evolving field of regenerative medicine that utilizes stem cells—undifferentiated cells capable of self-renewal and differentiation—to repair or replace damaged tissues and organs. In India, the therapy is increasingly being applied to conditions such as Leukaemia, Thalassemia, burn injuries, and corneal damage, offering hope to patients who previously had limited treatment options.

Body

What is Stem Cell Therapy?

Stem cell therapy involves the isolation, culture, and transplantation of stem cells to treat or prevent disease. Depending on the condition, different types of stem cells are used:

  • Hematopoietic Stem Cells (HSCs): Found in bone marrow, peripheral blood, and umbilical cord blood. Used in treating blood-related disorders like Leukaemia and Thalassemia through bone marrow or cord blood transplant.
  • Mesenchymal Stem Cells (MSCs): Derived from bone marrow, fat, or umbilical cord. Used for repairing bone, cartilage, and soft tissues and regenerating damaged skin in burn victims.
  • Limbal Stem Cells: Found in the eye and used to regenerate the corneal surface, restoring vision in cases of chemical burns or injury.
  • Embryonic Stem Cells and Induced Pluripotent Stem Cells (iPSCs): Though less commonly used due to ethical and safety concerns, these are capable of becoming any cell type and are vital for research.

Applications in India

  1. Leukaemia & Thalassemia: Stem cell transplants replace defective bone marrow, offering a potential cure.
  2. Corneal Damage: Limbal stem cell therapy restores sight without requiring full corneal transplant.
  3. Burn Injuries: Cultured skin grafts using stem cells speed up recovery and minimize scarring.
  4. Ongoing Research: Promising results in Parkinson’s disease, diabetes, spinal cord injuries, cardiac repair, and stroke recovery.

Advantages over Conventional Treatments

Parameter

Stem Cell Therapy

Conventional Treatment

Regeneration

Repairs damaged tissue at cellular level

Often manages symptoms

Availability

Can use patient’s own cells

Dependent on organ donors

Rejection Risk

Low (autologous therapy)

High in transplants

Scope

Multi-disease applicability

Often disease-specific

Invasiveness

Minimally invasive procedures

Often requires surgery

Recovery

Faster healing and reduced complications

Slower, with more side effects

Challenges in Implementation

  • High Cost and Limited Access: Affordability and lack of infrastructure in rural areas hinder access.
  • Regulatory Oversight: Need for strict ethical guidelines and clinical trial regulations to avoid misuse.
  • Standardization Issues: Variability in procedures and outcomes makes it hard to replicate successes.

Conclusion

Stem cell therapy represents a revolutionary shift in medical treatment, with the potential to transform healthcare by replacing organ transplants, enabling regenerative healing, and reducing long-term complications. As India expands its biotech and medical research ecosystem, responsible adoption of stem cell therapies will significantly improve outcomes for a wide range of debilitating conditions, especially among those with limited conventional treatment options.

Q.8) Can overuse and free availability of antibiotics without doctor’s prescription be contributors to the emergence of drug-resistant diseases in India? What are the available mechanisms for monitoring and control? Critically discuss the various issues involved.

Introduction

Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi, and parasites evolve to resist the effects of medicines, making common infections harder to treat. In India, the overuse and unregulated sale of antibiotics without prescription is a major cause for concern and a key contributor to the rise of drug-resistant diseases.

Body

How Overuse and Free Availability Contribute to Drug Resistance

  • Misuse and Overuse: Rampant self-medication and over-prescription of antibiotics promote selection pressure that favors resistant microbes.
  • Unregulated Antibiotic Market: Easy availability of antibiotics over-the-counter encourages irrational consumption, especially in rural and urban informal sectors.
  • Horizontal Gene Transfer: Resistant traits can spread among microbes, leading to widespread resistance even to powerful, last-resort antibiotics.
  • Environmental Contamination: Improper disposal and antibiotic-laden animal feed amplify resistance in the environment.

AMR Concerns in India      

  • High Mortality and Morbidity: According to the 2021 Lancet report, 1.27 million deaths globally were directly attributed to bacterial AMR, with India among the worst-affected, particularly among newborns.
  • High Burden of Infectious Diseases: Diseases like TB, typhoid, cholera, and pneumonia are becoming increasingly hard to treat due to AMR.
  • Lack of Surveillance: AMR data remains fragmented. India lacks a strong integrated national AMR surveillance system.
  • Poor Sanitation and Infection Control: Lack of WASH (Water, Sanitation, and Hygiene) increases the spread of infections and thus the demand for antibiotics.
  • Limited Innovation: Few new antibiotics are being developed, and India faces gaps in R&D for affordable alternatives.

Mechanisms for Monitoring and Control

  1. National Action Plan on AMR (2017): Aims to improve awareness, surveillance, and reduce antibiotic misuse.
  2. Delhi Declaration on AMR: An inter-ministerial commitment to tackle AMR with multi-sectoral engagement.
  3. Antibiotic Stewardship Program (AMSP): ICMR-led initiative in 20 tertiary hospitals to monitor rational antibiotic use.
  4. Ban on Fixed Dose Combinations (FDCs): 40 irrational FDCs have been banned by the Drug Controller General of India.
  5. Ban on Colistin in Animal Feed: Colistin, a last-resort antibiotic, has been banned as a growth promoter in poultry.
  6. One Health Approach: Integrated human-animal-environment response to AMR.
  7. Integrated AMR Surveillance Network: Collaboration between ICMR and ICAR to build AMR tracking capacity in veterinary labs.

Additional Measures to Combat AMR

  • Public Awareness: Educating citizens about responsible antibiotic use is key to changing behavior.
  • Stronger Regulation: Enforcement against illegal antibiotic sales and tighter prescription protocols are necessary.
  • International Collaboration: India can learn from best practices in the US and UK, such as setting national targets and investing in innovation.
  • Local Programs: Use of existing schemes like Kayakalp or Free Diagnostic Services to promote hygiene and infection control.
  • Academic and Civil Society Role: Promote research, training, and public engagement for AMR control.

Conclusion

The overuse and free availability of antibiotics have significantly fueled the emergence of drug-resistant infections in India. While several government measures are in place, the scale and urgency of the AMR crisis require stringent enforcement, multi-stakeholder collaboration, public education, and sustained innovation. Without immediate action, AMR threatens to undo decades of progress in health care and disease control.

Q.9) What do you understand by Fixed Dose Drug Combinations (FDCs)? Discuss their merits and demerits.

Introduction

Fixed Dose Drug Combinations (FDCs) are pharmaceutical formulations that combine two or more active drugs in a fixed ratio into a single dosage form (tablet, capsule, syrup, etc.). They are commonly used to treat diseases requiring multidrug therapy such as tuberculosis, HIV/AIDS, malaria, and hypertension.

Body

Merits of FDCs

  1. Improved Patient Compliance: A single pill with multiple drugs reduces pill burden, especially for chronic diseases, improving adherence to treatment regimens.
  2. Simplified Logistics: FDCs simplify prescribing, packaging, and distribution, which is especially helpful in public health systems.
  3. Synergistic Effects: Some combinations enhance therapeutic efficacy through synergism (e.g., antitubercular therapy).
  4. Cost-Effective: Reduced costs for packaging, transport, and procurement make FDCs economically beneficial, particularly in resource-poor settings.
  5. Prevention of Resistance: In infections like TB or HIV, FDCs ensure all necessary drugs are taken together, reducing the risk of drug resistance due to monotherapy.

Demerits of FDCs

  1. Lack of Individual Dose Adjustment: Fixed ratios may not suit all patients; dose adjustments for one drug may not be possible without altering the whole combination.
  2. Increased Risk of Adverse Effects: Combining multiple drugs may elevate the chance of side effects, drug-drug interactions, or cumulative toxicity.
  3. Unnecessary Medication: FDCs may expose patients to drugs they don’t need, especially in irrational combinations.
  4. Regulatory and Quality Concerns: In countries like India, unregulated production of irrational FDCs has led to misuse. This prompted the DCGI to ban several irrational FDCs.
  5. Complicated Diagnosis: Adverse reactions or therapeutic failure become difficult to trace to a single component in the combination.

Conclusion

While FDCs play a critical role in improving therapeutic outcomes and reducing drug resistance in specific diseases, their irrational use poses public health risks. A careful balance of scientific justification, clinical need, and regulatory oversight is essential to maximize their benefits and minimize harm. India’s recent actions, such as banning inappropriate FDCs, are steps in the right direction to ensure safe and effective use of such combinations.

 Starts @ April 6th

APPSC GROUP 1 NIRANTARA SADHANA - 2026APPSC GROUP 2 NIRANTARA SADHANA - 2026APPSC Group-1 Preparation Booster -Test Series 2026APPSC Group-II Preparation Booster – 4500+ MCQs Test SeriesTGPSC GROUP 1 NIRANTARA SADHANA - 2026TGPSC GROUP 2 NIRANTARA SADHANA - 2026
Scroll to Top